1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Xymogen

Anonymous board for Xymogen


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    24
    Views:
    22,790
  2. Anonymous
    Replies:
    58
    Views:
    22,628
  3. anonymous
    Replies:
    0
    Views:
    1,123
  4. Anonymous
    Replies:
    5
    Views:
    3,182
  5. Anonymous
    Replies:
    8
    Views:
    5,987
  6. Anonymous
    Replies:
    5
    Views:
    4,166
  7. Anonymous
    Replies:
    0
    Views:
    3,197
  8. Anonymous
    Replies:
    20
    Views:
    19,245
  9. Anonymous
    Replies:
    54
    Views:
    18,965
  10. Anonymous
    Replies:
    4
    Views:
    4,471
  11. Anonymous
    Replies:
    12
    Views:
    6,631
  12. Anonymous
    Replies:
    5
    Views:
    4,268
  13. Anonymous
    Replies:
    4
    Views:
    4,362
  14. Anonymous
    Replies:
    44
    Views:
    24,205
  15. Anonymous
    Replies:
    3
    Views:
    3,972
  16. Anonymous
    Replies:
    34
    Views:
    10,386
  17. Anonymous
    Replies:
    8
    Views:
    4,911
  18. Anonymous
    Replies:
    0
    Views:
    2,944
  19. Anonymous
    Replies:
    7
    Views:
    5,034
  20. Anonymous
    Replies:
    0
    Views:
    3,468

Thread Display Options

Loading...